,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1432279,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6257,RXRB,https://ctdbase.org/detail.go?type=gene&acc=6257,,,6257.0,RXRB,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RXRB mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
1,1432280,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RXRG mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
2,1432281,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,10329,RXYLT1,https://ctdbase.org/detail.go?type=gene&acc=10329,,,10329.0,RXYLT1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RXYLT1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3,1432282,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,23429,RYBP,https://ctdbase.org/detail.go?type=gene&acc=23429,,,23429.0,RYBP,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RYBP mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
4,1452581,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,54733,SLC35F2,https://ctdbase.org/detail.go?type=gene&acc=54733,,,54733.0,SLC35F2,10090.0,Mus musculus (house mouse),[dietary fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of SLC35F2 mRNA,,,PMID:33483757,https://www.ncbi.nlm.nih.gov/pubmed/33483757,33483757,,
5,1452582,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,148641,SLC35F3,https://ctdbase.org/detail.go?type=gene&acc=148641,,,148641.0,SLC35F3,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SLC35F3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
6,1452583,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,54978,SLC35F6,https://ctdbase.org/detail.go?type=gene&acc=54978,,,54978.0,SLC35F6,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SLC35F6 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
7,1452584,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,54020,SLC37A1,https://ctdbase.org/detail.go?type=gene&acc=54020,,,54020.0,SLC37A1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SLC37A1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
8,1452585,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,219855,SLC37A2,https://ctdbase.org/detail.go?type=gene&acc=219855,,,219855.0,SLC37A2,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SLC37A2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
9,1452586,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,2542,SLC37A4,https://ctdbase.org/detail.go?type=gene&acc=2542,,,2542.0,SLC37A4,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SLC37A4 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
10,1454218,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6674,SPAG1,https://ctdbase.org/detail.go?type=gene&acc=6674,,,6674.0,SPAG1,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SPAG1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
11,1454219,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10615,SPAG5,https://ctdbase.org/detail.go?type=gene&acc=10615,,,10615.0,SPAG5,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SPAG5 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
12,1454220,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,64663,SPANXC,https://ctdbase.org/detail.go?type=gene&acc=64663,,,64663.0,SPANXC,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SPANXC mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
13,1454221,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SPARC mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
14,1454222,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SPARC mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
15,1369343,68844,BindingDB,Brinzolamide,10885,"(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1,7,2-thieno[3,2-e][1,2]thiazine-6-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10885,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,,,PMID:9865942|DOI:10.1002/pro.5560071201,https://www.ncbi.nlm.nih.gov/pubmed/9865942|https://doi.org/10.1002/pro.5560071201,9865942,10.1002/pro.5560071201,
16,1369344,68995,Comparative Toxicogenomics Database (CTD),o-Cresolphthalein,C010092,cresolphthalein,https://ctdbase.org/detail.go?type=chem&acc=C010092,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Cresolphthalein results in decreased activity of AKR1C1 protein,,,PMID:12604236,https://www.ncbi.nlm.nih.gov/pubmed/12604236,12604236,,
17,1369345,68995,Comparative Toxicogenomics Database (CTD),o-Cresolphthalein,C010092,cresolphthalein,https://ctdbase.org/detail.go?type=chem&acc=C010092,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606.0,Homo sapiens (human),Cresolphthalein results in decreased activity of AKR1C2 protein,,,PMID:12604236,https://www.ncbi.nlm.nih.gov/pubmed/12604236,12604236,,
18,1454078,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,6945,MLX,https://ctdbase.org/detail.go?type=gene&acc=6945,,,6945.0,MLX,10116.0,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MLX mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
19,1454079,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,4594,MMUT,https://ctdbase.org/detail.go?type=gene&acc=4594,,,4594.0,MMUT,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in decreased expression of MMUT mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
20,1454080,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,23164,MPRIP,https://ctdbase.org/detail.go?type=gene&acc=23164,,,23164.0,MPRIP,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of MPRIP mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
21,1452436,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,9606.0,Homo sapiens (human),"[IFNG protein co-treated with 4,4'-hexafluorisopropylidene diphenol] inhibits the reaction [[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone] results in increased expression of HSPD1 protein]",,,PMID:31596606,https://www.ncbi.nlm.nih.gov/pubmed/31596606,31596606,,
22,1452437,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of HSPE1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
23,1452438,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100529241,HSPE1-MOB4,https://ctdbase.org/detail.go?type=gene&acc=100529241,,,100529241.0,HSPE1-MOB4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of HSPE1-MOB4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
24,1453218,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL1B protein|4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL1B mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
25,1453219,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL1B mRNA",,,PMID:36801538|PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/36801538|https://www.ncbi.nlm.nih.gov/pubmed/37423901,36801538|37423901,,
26,1453220,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,7955.0,Danio rerio (zebrafish),"Curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of IL1B mrna]",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
27,1453221,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,568868,IL1RAPL1A,https://ctdbase.org/detail.go?type=gene&acc=568868,,,568868.0,il1rapl1a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL1RAPL1A mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
28,1453222,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11009,IL24,https://ctdbase.org/detail.go?type=gene&acc=11009,,,11009.0,IL24,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of IL24 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
29,1453354,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3560,IL2RB,https://ctdbase.org/detail.go?type=gene&acc=3560,,,3560.0,IL2RB,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL2RB mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
30,1453355,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL6 mrna|curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of IL6 mrna]",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
31,1453356,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IL6 protein",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
32,1453357,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3608,ILF2,https://ctdbase.org/detail.go?type=gene&acc=3608,,,3608.0,ILF2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ILF2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
33,1453358,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3609,ILF3,https://ctdbase.org/detail.go?type=gene&acc=3609,,,3609.0,ILF3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ILF3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
34,1453359,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3611,ILK,https://ctdbase.org/detail.go?type=gene&acc=3611,,,3611.0,ILK,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to ILK protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
35,1453515,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,64423,INF2,https://ctdbase.org/detail.go?type=gene&acc=64423,,,64423.0,INF2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of INF2 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
36,1453516,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3625,INHBB,https://ctdbase.org/detail.go?type=gene&acc=3625,,,3625.0,INHBB,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of INHBB mRNA",,,PMID:22504055,https://www.ncbi.nlm.nih.gov/pubmed/22504055,22504055,,
37,1453517,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of INHBE mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
38,1453518,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in increased expression of INHBE mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
39,1453519,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of INS mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
40,1453520,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4033,IRAG2,https://ctdbase.org/detail.go?type=gene&acc=4033,,,4033.0,IRAG2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of IRAG2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
41,1453521,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,9606.0,Homo sapiens (human),"IFNG protein promotes the reaction [4,4'-hexafluorisopropylidene diphenol inhibits the reaction [[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone] results in decreased expression of IRF1 mrna]]|4,4'-hexafluorisopropylidene diphenol inhibits the reaction [[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone] results in decreased expression of IRF1 mrna]",,,PMID:31596606,https://www.ncbi.nlm.nih.gov/pubmed/31596606,31596606,,
42,1460317,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54148,MRPL39,https://ctdbase.org/detail.go?type=gene&acc=54148,,,54148.0,MRPL39,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MRPL39 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
43,1452299,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PRDX5 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
44,1452300,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of PRDX6 mRNA,,,PMID:16221955,https://www.ncbi.nlm.nih.gov/pubmed/16221955,16221955,,
45,1452301,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10113,PREB,https://ctdbase.org/detail.go?type=gene&acc=10113,,,10113.0,PREB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PREB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
46,1452302,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,393337,PRELID1A,https://ctdbase.org/detail.go?type=gene&acc=393337,,,393337.0,prelid1a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRELID1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
47,1452303,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,553707,PRELID1B,https://ctdbase.org/detail.go?type=gene&acc=553707,,,553707.0,prelid1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRELID1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
48,1452304,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,153768,PRELID2,https://ctdbase.org/detail.go?type=gene&acc=153768,,,153768.0,PRELID2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRELID2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
49,1452305,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5549,PRELP,https://ctdbase.org/detail.go?type=gene&acc=5549,,,5549.0,PRELP,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRELP mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
50,1452882,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5589,PRKCSH,https://ctdbase.org/detail.go?type=gene&acc=5589,,,5589.0,PRKCSH,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRKCSH mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
51,1452883,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5590,PRKCZ,https://ctdbase.org/detail.go?type=gene&acc=5590,,,5590.0,PRKCZ,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PRKCZ mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
52,1452884,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased phosphorylation of PRKD1 protein,,,PMID:36106993,https://www.ncbi.nlm.nih.gov/pubmed/36106993,36106993,,
53,1452885,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PRKD1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
54,1452886,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRKD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
55,1452887,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25865,PRKD2,https://ctdbase.org/detail.go?type=gene&acc=25865,,,25865.0,PRKD2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PRKD2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
56,1453071,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25865,PRKD2,https://ctdbase.org/detail.go?type=gene&acc=25865,,,25865.0,PRKD2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PRKD2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
57,1453072,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23683,PRKD3,https://ctdbase.org/detail.go?type=gene&acc=23683,,,23683.0,PRKD3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PRKD3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
58,1453073,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23683,PRKD3,https://ctdbase.org/detail.go?type=gene&acc=23683,,,23683.0,PRKD3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PRKD3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
59,1453074,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PRKDC mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
60,1453075,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRKDC mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
61,1453076,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5592,PRKG1,https://ctdbase.org/detail.go?type=gene&acc=5592,,,5592.0,PRKG1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRKG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
62,1453077,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5071,PRKN,https://ctdbase.org/detail.go?type=gene&acc=5071,,,5071.0,PRKN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRKN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
63,1453078,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8575,PRKRA,https://ctdbase.org/detail.go?type=gene&acc=8575,,,8575.0,PRKRA,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PRKRA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
64,1453079,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5613,PRKX,https://ctdbase.org/detail.go?type=gene&acc=5613,,,5613.0,PRKX,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PRKX mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
65,1453080,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5618,PRLR,https://ctdbase.org/detail.go?type=gene&acc=5618,,,5618.0,PRLR,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PRLR mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PRLR mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PRLR mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
66,1453350,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56474,CTPS2,https://ctdbase.org/detail.go?type=gene&acc=56474,,,56474.0,CTPS2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CTPS2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
67,1453351,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56474,CTPS2,https://ctdbase.org/detail.go?type=gene&acc=56474,,,56474.0,CTPS2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CTPS2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CTPS2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
68,1453352,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1504,CTRB1,https://ctdbase.org/detail.go?type=gene&acc=1504,,,1504.0,CTRB1,7962.0,Cyprinus carpio (common carp),Perfluorooctane sulfonic acid results in decreased expression of CTRB1 mRNA,,,PMID:18501439,https://www.ncbi.nlm.nih.gov/pubmed/18501439,18501439,,
69,1453353,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CTSB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
70,1453946,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
71,1453947,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606.0,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
72,1453948,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
73,1453949,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
74,1453950,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606.0,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
75,1453951,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606.0,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
76,1499777,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF4E mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
77,1499778,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,253314,EIF4E1B,https://ctdbase.org/detail.go?type=gene&acc=253314,,,253314.0,EIF4E1B,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EIF4E1B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
78,1499779,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,550549,EIF4E1C,https://ctdbase.org/detail.go?type=gene&acc=550549,,,550549.0,eif4e1c,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of EIF4E1C mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
79,1499780,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,9470,EIF4E2,https://ctdbase.org/detail.go?type=gene&acc=9470,,,9470.0,EIF4E2,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EIF4E2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
80,1499781,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,317649,EIF4E3,https://ctdbase.org/detail.go?type=gene&acc=317649,,,317649.0,EIF4E3,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF4E3 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
81,1452587,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,54438,GFOD1,https://ctdbase.org/detail.go?type=gene&acc=54438,,,54438.0,GFOD1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of GFOD1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
82,1452588,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,100507003,GFY,https://ctdbase.org/detail.go?type=gene&acc=100507003,,,100507003.0,GFY,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of GFY mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
83,1452589,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,87769,GGACT,https://ctdbase.org/detail.go?type=gene&acc=87769,,,87769.0,GGACT,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of GGACT mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
84,1452590,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,54994,GID8,https://ctdbase.org/detail.go?type=gene&acc=54994,,,54994.0,GID8,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of GID8 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
85,1454344,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,429,ASCL1,https://ctdbase.org/detail.go?type=gene&acc=429,,,429.0,ASCL1,9606.0,Homo sapiens (human),Deguelin results in increased expression of ASCL1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
86,1522731,115196,Comparative Toxicogenomics Database (CTD),Brassinolide,C023623,brassinolide,https://ctdbase.org/detail.go?type=chem&acc=C023623,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Brassinolide results in increased expression of CDKN1A protein,,,PMID:20833159,https://www.ncbi.nlm.nih.gov/pubmed/20833159,20833159,,
87,1475723,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,8751,ADAM15,https://ctdbase.org/detail.go?type=gene&acc=8751,,,8751.0,ADAM15,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of ADAM15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
88,1475724,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,56999,ADAMTS9,https://ctdbase.org/detail.go?type=gene&acc=56999,,,56999.0,ADAMTS9,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of ADAMTS9 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
89,1475725,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,54507,ADAMTSL4,https://ctdbase.org/detail.go?type=gene&acc=54507,,,54507.0,ADAMTSL4,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of ADAMTSL4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
90,1475726,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,84059,ADGRV1,https://ctdbase.org/detail.go?type=gene&acc=84059,,,84059.0,ADGRV1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of ADGRV1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
91,1475413,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6324,SCN1B,https://ctdbase.org/detail.go?type=gene&acc=6324,,,6324.0,SCN1B,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of SCN1B mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
92,1418331,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,3914,LAMB3,https://ctdbase.org/detail.go?type=gene&acc=3914,,,3914.0,LAMB3,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of LAMB3 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
93,1452439,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,3936,LCP1,https://ctdbase.org/detail.go?type=gene&acc=3936,,,3936.0,LCP1,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of LCP1 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
94,1452440,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,37963,LCP9,https://ctdbase.org/detail.go?type=gene&acc=37963,,,37963.0,Lcp9,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of LCP9 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
95,1452441,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606.0,Homo sapiens (human),Bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of LDLR mrna],,,PMID:24170205,https://www.ncbi.nlm.nih.gov/pubmed/24170205,24170205,,
96,1452442,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,43223,LERP,https://ctdbase.org/detail.go?type=gene&acc=43223,,,43223.0,Lerp,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of LERP mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
97,1452443,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,45325,LIN,https://ctdbase.org/detail.go?type=gene&acc=45325,,,45325.0,lin,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of LIN mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
98,1452444,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,36791,LIS-1,https://ctdbase.org/detail.go?type=gene&acc=36791,,,36791.0,Lis-1,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of LIS-1 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
99,1452445,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,39889,LMPT,https://ctdbase.org/detail.go?type=gene&acc=39889,,,39889.0,Lmpt,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of LMPT mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
100,1453223,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,32913,MUC18B,https://ctdbase.org/detail.go?type=gene&acc=32913,,,32913.0,Muc18B,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of MUC18B mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
101,1453224,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of MYC mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
102,1453225,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,38153,MYO61F,https://ctdbase.org/detail.go?type=gene&acc=38153,,,38153.0,Myo61F,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of MYO61F mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
103,1453226,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,24142,NAA80,https://ctdbase.org/detail.go?type=gene&acc=24142,,,24142.0,NAA80,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of NAA80 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
104,1453227,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4745,NELL1,https://ctdbase.org/detail.go?type=gene&acc=4745,,,4745.0,NELL1,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of NELL1 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
105,1452158,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284312,ZSCAN1,https://ctdbase.org/detail.go?type=gene&acc=284312,,,284312.0,ZSCAN1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZSCAN1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
106,1454212,208898,Drug Gene Interaction database (DGIdb),Dronedarone,,DRONEDARONE,https://www.dgidb.org/drugs/rxcui:233698,,KCNH2,https://www.dgidb.org/genes/hgnc:6251,,,3757.0,KCNH2,9606.0,Homo sapiens (human),,,,,,,,
107,1454213,208898,Drug Gene Interaction database (DGIdb),Dronedarone,,DRONEDARONE,https://www.dgidb.org/drugs/rxcui:233698,,ADRA1A,https://www.dgidb.org/genes/hgnc:277,,,148.0,ADRA1A,9606.0,Homo sapiens (human),,,,,,,,
108,1454214,208901,ChEMBL,Tesaglitazar,CHEMBL282686,TESAGLITAZAR,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL282686/,CHEMBL239,Peroxisome proliferator-activated receptor alpha,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL239/,Q07869,Peroxisome proliferator-activated receptor alpha,5465.0,PPARA,9606.0,Homo sapiens (human),Peroxisome proliferator-activated receptor alpha agonist,,,PMID:15059948|PMID:16628256,https://www.ncbi.nlm.nih.gov/pubmed/15059948|https://www.ncbi.nlm.nih.gov/pubmed/16628256,15059948|16628256,,
109,1454215,208901,ChEMBL,Tesaglitazar,CHEMBL282686,TESAGLITAZAR,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL282686/,CHEMBL235,Peroxisome proliferator-activated receptor gamma,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL235/,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),Peroxisome proliferator-activated receptor gamma agonist,,,PMID:15059948|PMID:16628256,https://www.ncbi.nlm.nih.gov/pubmed/15059948|https://www.ncbi.nlm.nih.gov/pubmed/16628256,15059948|16628256,,
110,1454216,208908,BindingDB,Lapatinib,5445,CHEMBL554,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5445,5143,Receptor tyrosine-protein kinase erbB-4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5143,Q15303,Receptor tyrosine-protein kinase erbB-4,2066.0,ERBB4,9606.0,Homo sapiens (human),,IC50 (nM),367.0,PMID:18287036|DOI:10.1073/pnas.0708281105,https://www.ncbi.nlm.nih.gov/pubmed/18287036|https://doi.org/10.1073/pnas.0708281105,18287036,10.1073/pnas.0708281105,
111,1454217,208908,BindingDB,Lapatinib,5445,CHEMBL554,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5445,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),11.0,PMID:18287036|DOI:10.1073/pnas.0708281105,https://www.ncbi.nlm.nih.gov/pubmed/18287036|https://doi.org/10.1073/pnas.0708281105,18287036,10.1073/pnas.0708281105,
112,1531814,300809,BindingDB,2-Amino-6-bromopyridine,98803,EN300-42473,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=98803,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),1920.0,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
113,1531815,304583,Comparative Toxicogenomics Database (CTD),"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-1-(phenylmethyl)-",C454676,N-3-benzylphenobarbital,https://ctdbase.org/detail.go?type=chem&acc=C454676,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),N-3-benzylphenobarbital results in decreased activity of CYP2C19 protein,,,PMID:21336516,https://www.ncbi.nlm.nih.gov/pubmed/21336516,21336516,,
114,1531816,308072,BindingDB,2-Amino-N-methylbenzamide,626061,EN300-17933,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626061,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),1940.0,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
115,1522732,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,10090.0,Mus musculus (house mouse),Bortezomib results in decreased expression of EGR2 protein|bortezomib results in decreased expression of EGR2 mRNA,,,PMID:20830808,https://www.ncbi.nlm.nih.gov/pubmed/20830808,20830808,,
116,1522733,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10919,EHMT2,https://ctdbase.org/detail.go?type=gene&acc=10919,,,10919.0,EHMT2,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EHMT2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
117,1522734,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of EIF1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
118,1522735,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,83939,EIF2A,https://ctdbase.org/detail.go?type=gene&acc=83939,,,83939.0,EIF2A,9606.0,Homo sapiens (human),Bortezomib results in decreased phosphorylation of EIF2A protein,,,PMID:18641367,https://www.ncbi.nlm.nih.gov/pubmed/18641367,18641367,,
119,1452292,398465,BindingDB,"9-Cyano-2,3-dimethoxypaullone",7265,"4,5-dimethoxy-9-oxo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaene-14-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7265,105,Cyclin-dependent kinase 5 activator 1 [99-307],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=105,Q15078,Cyclin-dependent kinase 5 activator 1,8851.0,CDK5R1,9606.0,Homo sapiens (human),,IC50 (nM),60.0,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
120,1452293,398465,BindingDB,"9-Cyano-2,3-dimethoxypaullone",7265,"4,5-dimethoxy-9-oxo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaene-14-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7265,91,Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=91,Q9DGD3,Cyclin-dependent kinase 1,100049478.0,cdk1,8090.0,Oryzias latipes (Japanese medaka),,IC50 (nM),44.0,PMID:10998059|DOI:10.1046/j.1432-1327.2000.01673.x,https://www.ncbi.nlm.nih.gov/pubmed/10998059|https://doi.org/10.1046/j.1432-1327.2000.01673.x,10998059,10.1046/j.1432-1327.2000.01673.x,
121,1452294,399457,Comparative Toxicogenomics Database (CTD),Omdpi,C435044,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,https://ctdbase.org/detail.go?type=chem&acc=C435044,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol results in decreased activity of AKT1 protein,,,PMID:15691865,https://www.ncbi.nlm.nih.gov/pubmed/15691865,15691865,,
122,1452295,399457,Comparative Toxicogenomics Database (CTD),Omdpi,C435044,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,https://ctdbase.org/detail.go?type=chem&acc=C435044,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased cleavage of CASP3 protein],,,PMID:22936809,https://www.ncbi.nlm.nih.gov/pubmed/22936809,22936809,,
123,1452296,399457,Comparative Toxicogenomics Database (CTD),Omdpi,C435044,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,https://ctdbase.org/detail.go?type=chem&acc=C435044,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased expression of HMOX1 protein],,,PMID:26385185,https://www.ncbi.nlm.nih.gov/pubmed/26385185,26385185,,
124,1452297,399457,Comparative Toxicogenomics Database (CTD),Omdpi,C435044,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,https://ctdbase.org/detail.go?type=chem&acc=C435044,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased phosphorylation of and results in increased activity of RELA protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased phosphorylation of SRC protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased cleavage of CASP3 protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in decreased expression of SIRT1 protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol results in decreased susceptibility to IL1B protein|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]|1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased expression of MMP9 protein],,,PMID:22936809,https://www.ncbi.nlm.nih.gov/pubmed/22936809,22936809,,
125,1452298,399457,Comparative Toxicogenomics Database (CTD),Omdpi,C435044,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,https://ctdbase.org/detail.go?type=chem&acc=C435044,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK8 protein],,,PMID:26385185,https://www.ncbi.nlm.nih.gov/pubmed/26385185,26385185,,
126,1453820,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1114,CHGB,https://ctdbase.org/detail.go?type=gene&acc=1114,,,1114.0,CHGB,10090.0,Mus musculus (house mouse),Lithium chloride results in decreased expression of CHGB mRNA,,,PMID:33901603,https://www.ncbi.nlm.nih.gov/pubmed/33901603,33901603,,
127,1453821,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,26973,CHORDC1,https://ctdbase.org/detail.go?type=gene&acc=26973,,,26973.0,CHORDC1,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of CHORDC1 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
128,1453822,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1158,CKM,https://ctdbase.org/detail.go?type=gene&acc=1158,,,1158.0,CKM,10090.0,Mus musculus (house mouse),Lithium chloride results in increased expression of CKM mRNA,,,PMID:20694829,https://www.ncbi.nlm.nih.gov/pubmed/20694829,20694829,,
129,1453823,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10090.0,Mus musculus (house mouse),Lithium chloride results in increased expression of CLDN1 mRNA,,,PMID:33901603,https://www.ncbi.nlm.nih.gov/pubmed/33901603,33901603,,
130,1452723,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,6530,SLC6A2,https://ctdbase.org/detail.go?type=gene&acc=6530,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),Norepinephrine results in decreased activity of SLC6A2 protein|norepinephrine results in decreased expression of SLC6A2 protein|norepinephrine inhibits the reaction [nisoxetine binds to SLC6A2 protein],,,PMID:11082428,https://www.ncbi.nlm.nih.gov/pubmed/11082428,11082428,,
131,1452724,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,6530,SLC6A2,https://ctdbase.org/detail.go?type=gene&acc=6530,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),SLC6A2 mutant form results in decreased uptake of norepinephrine,,,PMID:11458707,https://www.ncbi.nlm.nih.gov/pubmed/11458707,11458707,,
132,1452725,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,6530,SLC6A2,https://ctdbase.org/detail.go?type=gene&acc=6530,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),SLC6A2 protein promotes the reaction [norepinephrine results in increased activity of TAAR1 protein],,,PMID:17234900,https://www.ncbi.nlm.nih.gov/pubmed/17234900,17234900,,
133,1452726,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,6530,SLC6A2,https://ctdbase.org/detail.go?type=gene&acc=6530,,,6530.0,SLC6A2,9544.0,Macaca mulatta (Rhesus monkey),SLC6A2 protein alternative form results in decreased transport of norepinephrine|slc6a2 protein affects the transport of norepinephrine,,,PMID:11223167,https://www.ncbi.nlm.nih.gov/pubmed/11223167,11223167,,
134,1453522,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),"N,N'-bis(salicylideneamino)ethane-manganese(ii) inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|oxophenylarsine inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|cadmium sulfate inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein|cadmium chloride inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|prazosin inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|diphenyleneiodonium inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of MAPK3 protein]",,,PMID:11880281,https://www.ncbi.nlm.nih.gov/pubmed/11880281,11880281,,
135,1453523,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased phosphorylation of MAPK3 protein],,,PMID:11054474,https://www.ncbi.nlm.nih.gov/pubmed/11054474,11054474,,
136,1453815,441348,ChEMBL,Chloroprocaine Hydrochloride,CHEMBL944,CHLOROPROCAINE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL944/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9UQD0,Sodium channel protein type 8 subunit alpha,6334.0,SCN8A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15635807,https://www.ncbi.nlm.nih.gov/pubmed/15635807,15635807,,
137,1453816,441348,ChEMBL,Chloroprocaine Hydrochloride,CHEMBL944,CHLOROPROCAINE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL944/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,PMID:15635807,https://www.ncbi.nlm.nih.gov/pubmed/15635807,15635807,,
138,1453817,441358,Drug Gene Interaction database (DGIdb),Nortriptyline Hydrochloride,,NORTRIPTYLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203130,,SLC6A2,https://www.dgidb.org/genes/hgnc:11048,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
139,1453818,441371,ChEMBL,Erythromycin Estolate,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218877/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02358,30S ribosomal protein S6,948723.0,rpsF,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
140,1453819,441371,ChEMBL,Erythromycin Estolate,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218877/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02359,30S ribosomal protein S7,947846.0,rpsG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
141,1452717,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,326977,ATP5L,https://ctdbase.org/detail.go?type=gene&acc=326977,,,326977.0,atp5l,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP5L mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
142,1452718,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,516,ATP5MC1,https://ctdbase.org/detail.go?type=gene&acc=516,,,516.0,ATP5MC1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP5MC1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
143,1452719,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,516,ATP5MC1,https://ctdbase.org/detail.go?type=gene&acc=516,,,516.0,ATP5MC1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of ATP5MC1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
144,1452720,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,516,ATP5MC1,https://ctdbase.org/detail.go?type=gene&acc=516,,,516.0,ATP5MC1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP5MC1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
145,1452721,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100505704,ATP5MC1P6,https://ctdbase.org/detail.go?type=gene&acc=100505704,,,100505704.0,ATP5MC1P6,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP5MC1P6 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
146,1452722,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,518,ATP5MC3,https://ctdbase.org/detail.go?type=gene&acc=518,,,518.0,ATP5MC3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP5MC3 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
147,1452888,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,394151,ATP5MC3A,https://ctdbase.org/detail.go?type=gene&acc=394151,,,394151.0,atp5mc3a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP5MC3A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
148,1452889,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,794625,ATP5MD,https://ctdbase.org/detail.go?type=gene&acc=794625,,,794625.0,atp5md,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP5MD mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
149,1452890,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,521,ATP5ME,https://ctdbase.org/detail.go?type=gene&acc=521,,,521.0,ATP5ME,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP5ME mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
150,1452891,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9551,ATP5MF,https://ctdbase.org/detail.go?type=gene&acc=9551,,,9551.0,ATP5MF,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP5MF mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
151,1453662,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ATP6V1C1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
152,1453663,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,368907,ATP6V1C1A,https://ctdbase.org/detail.go?type=gene&acc=368907,,,368907.0,atp6v1c1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1C1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
153,1453664,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,449655,ATP6V1C1B,https://ctdbase.org/detail.go?type=gene&acc=449655,,,449655.0,atp6v1c1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1C1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
154,1453665,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,245973,ATP6V1C2,https://ctdbase.org/detail.go?type=gene&acc=245973,,,245973.0,ATP6V1C2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATP6V1C2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
155,1453666,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51382,ATP6V1D,https://ctdbase.org/detail.go?type=gene&acc=51382,,,51382.0,ATP6V1D,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1D mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
156,1453667,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,529,ATP6V1E1,https://ctdbase.org/detail.go?type=gene&acc=529,,,529.0,ATP6V1E1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ATP6V1E1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
157,1453668,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,529,ATP6V1E1,https://ctdbase.org/detail.go?type=gene&acc=529,,,529.0,ATP6V1E1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of ATP6V1E1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
158,1453669,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,108179059,ATP6V1E1A,https://ctdbase.org/detail.go?type=gene&acc=108179059,,,108179059.0,atp6v1e1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1E1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
159,1453670,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,192335,ATP6V1E1B,https://ctdbase.org/detail.go?type=gene&acc=192335,,,192335.0,atp6v1e1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATP6V1E1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
160,1453671,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,90423,ATP6V1E2,https://ctdbase.org/detail.go?type=gene&acc=90423,,,90423.0,ATP6V1E2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ATP6V1E2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
161,1453942,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,152926,PPM1K,https://ctdbase.org/detail.go?type=gene&acc=152926,,,152926.0,PPM1K,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PPM1K mRNA,,,PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,29301061|34032870,,
162,1453943,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,564838,PPP1R14BA,https://ctdbase.org/detail.go?type=gene&acc=564838,,,564838.0,ppp1r14ba,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PPP1R14BA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
163,1453944,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,151742,PPM1L,https://ctdbase.org/detail.go?type=gene&acc=151742,,,151742.0,PPM1L,9606.0,Homo sapiens (human),Sodium arsenite results in increased methylation of PPM1L gene|sodium arsenite deficiency inhibits the reaction [sodium arsenite results in increased expression of PPM1L mrna]|[sodium arsenite co-treated with sodium arsenite deficiency] results in increased methylation of PPM1L gene,,,PMID:28336213,https://www.ncbi.nlm.nih.gov/pubmed/28336213,28336213,,
164,1453945,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,151742,PPM1L,https://ctdbase.org/detail.go?type=gene&acc=151742,,,151742.0,PPM1L,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PPM1L mRNA,,,PMID:22714537|PMID:28336213,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/28336213,22714537|28336213,,
165,1454081,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,132160,PPM1M,https://ctdbase.org/detail.go?type=gene&acc=132160,,,132160.0,PPM1M,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PPM1M mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
166,1454082,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,564875,PPM1NB,https://ctdbase.org/detail.go?type=gene&acc=564875,,,564875.0,ppm1nb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PPM1NB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
167,1454083,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51400,PPME1,https://ctdbase.org/detail.go?type=gene&acc=51400,,,51400.0,PPME1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PPME1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
168,1454084,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51400,PPME1,https://ctdbase.org/detail.go?type=gene&acc=51400,,,51400.0,PPME1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PPME1 mrna|sodium arsenite deficiency promotes the reaction [sodium arsenite results in increased expression of PPME1 mrna]|sodium arsenite results in increased methylation of PPME1 promoter,,,PMID:28336213,https://www.ncbi.nlm.nih.gov/pubmed/28336213,28336213,,
169,1454085,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5499,PPP1CA,https://ctdbase.org/detail.go?type=gene&acc=5499,,,5499.0,PPP1CA,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [LRRK2 protein binds to PPP1CA protein],,,PMID:24942733,https://www.ncbi.nlm.nih.gov/pubmed/24942733,24942733,,
170,1454086,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5499,PPP1CA,https://ctdbase.org/detail.go?type=gene&acc=5499,,,5499.0,PPP1CA,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PPP1CA protein,,,PMID:15725613,https://www.ncbi.nlm.nih.gov/pubmed/15725613,15725613,,
171,1454087,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5499,PPP1CA,https://ctdbase.org/detail.go?type=gene&acc=5499,,,5499.0,PPP1CA,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of PPP1CA protein]|sodium arsenite results in increased phosphorylation of PPP1CA protein,,,PMID:27966075,https://www.ncbi.nlm.nih.gov/pubmed/27966075,27966075,,
172,1558006,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55526,DHTKD1,https://ctdbase.org/detail.go?type=gene&acc=55526,,,55526.0,DHTKD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHTKD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
173,1558007,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55526,DHTKD1,https://ctdbase.org/detail.go?type=gene&acc=55526,,,55526.0,DHTKD1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of DHTKD1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
174,1492261,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,2520,GAST,https://ctdbase.org/detail.go?type=gene&acc=2520,,,2520.0,GAST,10116.0,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased secretion of GAST protein,,,PMID:19208342,https://www.ncbi.nlm.nih.gov/pubmed/19208342,19208342,,
175,1492262,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,10036.0,Mesocricetus auratus (golden hamster),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [GCG protein results in increased secretion of INS1 protein],,,PMID:16837018,https://www.ncbi.nlm.nih.gov/pubmed/16837018,16837018,,
176,1492399,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,8404.0,Lithobates pipiens (northern leopard frog),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased phosphorylation of CREB1 protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased expression of BDNF mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased expression of NTRK2 mrna],,,PMID:16269011,https://www.ncbi.nlm.nih.gov/pubmed/16269011,16269011,,
177,1610290,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10116.0,Rattus norvegicus (Norway rat),Cardamonin inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of NFKB1 protein],,,PMID:28966130,https://www.ncbi.nlm.nih.gov/pubmed/28966130,28966130,,
178,1610291,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Cardamonin inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of NOS2 mrna],,,PMID:28966130,https://www.ncbi.nlm.nih.gov/pubmed/28966130,28966130,,
179,1610292,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116.0,Rattus norvegicus (Norway rat),Cardamonin inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in decreased expression of NOS3 mrna],,,PMID:28966130,https://www.ncbi.nlm.nih.gov/pubmed/28966130,28966130,,
180,1610293,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Cardamonin results in increased cleavage of PARP1 protein,,,PMID:37268255,https://www.ncbi.nlm.nih.gov/pubmed/37268255,37268255,,
181,1610294,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Cardamonin inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:22696397,https://www.ncbi.nlm.nih.gov/pubmed/22696397,22696397,,
182,1610295,641785,Comparative Toxicogenomics Database (CTD),Cardamonin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Cardamonin inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of TNF protein],,,PMID:28966130,https://www.ncbi.nlm.nih.gov/pubmed/28966130,28966130,,
183,1610296,641786,Therapeutic Target Database (TTD),"(4R,5R)-4,5-dihydroxy-2,6,6-trimethylcyclohexene-1-carbaldehyde",D04XED,Crocusatin-K,https://idrblab.net/ttd/data/drug/details/D04XED,T97035,Tyrosinase (TYR),https://idrblab.net/ttd/data/target/details/T97035,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
184,1610297,641819,BindingDB,4-Methoxychalcone,86005,"Chalcone, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=86005,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,IC50 (nM),39000.0,PMID:15895683|DOI:10.1080/14756360400015231,https://www.ncbi.nlm.nih.gov/pubmed/15895683|https://doi.org/10.1080/14756360400015231,15895683,10.1080/14756360400015231,
185,1610298,643460,Drug Gene Interaction database (DGIdb),Sorbic Acid,,SORBIC ACID,https://www.dgidb.org/drugs/rxcui:1311139,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
186,2002340,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,11181,TREH,https://ctdbase.org/detail.go?type=gene&acc=11181,,,11181.0,TREH,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TREH mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
187,2030696,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3062,HCRTR2,https://ctdbase.org/detail.go?type=gene&acc=3062,,,3062.0,HCRTR2,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of HCRTR2 mRNA,,,PMID:15590111,https://www.ncbi.nlm.nih.gov/pubmed/15590111,15590111,,
188,2037980,23646736,BindingDB,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,14354,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14354,1529,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1529,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,Ki (nM),37.0,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
189,2037981,23646736,BindingDB,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,14354,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14354,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),240.0,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
190,2037982,23646736,BindingDB,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,14354,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14354,5163,Urokinase-type plasminogen activator,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5163,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),,Ki (nM),3.2,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
191,2037983,23646736,BindingDB,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,14354,2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-4-(dimethylcarbamoyl)-6-phenylbenzen-1-olate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14354,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),52.0,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
192,2015207,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),,,,,,,,
193,2056991,24901565,BindingDB,"N-[3-(diethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-4-methyl-1,3-thiazole-5-carboxamide",24156,"N-[3-(diethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-4-methyl-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24156,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,IC50 (nM),17000.0,PMID:17498954|DOI:10.1016/j.bmcl.2007.04.076,https://www.ncbi.nlm.nih.gov/pubmed/17498954|https://doi.org/10.1016/j.bmcl.2007.04.076,17498954,10.1016/j.bmcl.2007.04.076,
